GranuFlo Lawsuits News: Calif. Lawsuit Alleges Drug Maker Hid Serious Health Risks, Rottenstein Law Group LLP Reports

Share Article

The firm is actively filing GranuFlo lawsuits on behalf of those who believe they suffered from the drug's alleged serious adverse side effects, such as heart attacks and irregular heartbeat.

The firm is actively filing GranuFlo lawsuits on behalf of those who believe they suffered from the drug's alleged serious adverse side effects, such as heart attacks and irregular heartbeat.

The firm is actively filing GranuFlo lawsuits on behalf of those who believe they suffered from the drug's alleged serious adverse side effects, such as heart attacks and irregular heartbeat.

If these very serious allegations are true, then the courts should hold this company accountable.

A group of plaintiffs have filed a GranuFlo lawsuit in California state court, alleging that drug maker Fresenius sold dialysis drug GranuFlo while failing to inform the public of the serious potential risks of use of the drug, including heart attack and stroke, according to court documents. The Rottenstein Law Group LLP, which represents clients in GranuFlo dialysis injury lawsuits, maintains a web page that features information on GranuFlo side effects and lawsuits.

In June 2012 the U.S. Food and Drug Administration issued a Class 1 Recall after learning about the alleged adverse side effects involving the heart.* The FDA had originally approved the drug for distribution in 2003. The plaintiffs argue in the lawsuit that Fresenius warned its doctors at its own dialysis centers about the health risks of GranuFlo, but it did not warn anyone outside the organization (Rodriguez et al. v. Fresenius USA Inc. et al.; BC519374, Los Angeles Superior Court, California). According to court documents, the FDA received a copy of the memo in March 2012 and subsequently took action.

“If these very serious allegations are true, then the courts should hold this company accountable,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. “The plaintiffs—and our own clients on whose behalf we file GranuFlo lawsuits—put their lives in the hands of this company and deserve justice.”

The Rottenstein Law Group LLP encourages those who believe they have suffered from the alleged side effects of GranuFlo to download a free informational brochure about the drug to learn more about its side effects and how to file a lawsuit.

*fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm305630.htm

About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com

                            ###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Rochelle Rottenstein, Esq.
@RotLaw
since: 10/2010
Follow >
The Rottenstein Law Group LLP
since: 01/2011
Like >
Follow us on
Visit website